2014
DOI: 10.1007/s10967-014-3101-6
|View full text |Cite
|
Sign up to set email alerts
|

Radio-immunoconjugated, Dox-loaded, surface-modified superparamagnetic iron oxide nanoparticles (SPIONs) as a bioprobe for breast cancer tumor theranostics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 14 publications
(4 citation statements)
references
References 15 publications
0
4
0
Order By: Relevance
“…Doxorubicin (DOX) is a commonly used anticancer drug which has been widely used in a variety of cancer chemotherapy, such as blood malignant tumor [1], a variety of adenocarcinoma [2][3][4][5], soft tissue sarcoma [6], and so on. However, long term and high dosages of DOX will lead to drug resistance [7], nausea [8], hair loss [9], and acute and chronic toxicity [10], which may lead to congestive heart failure [11].…”
Section: Introductionmentioning
confidence: 99%
“…Doxorubicin (DOX) is a commonly used anticancer drug which has been widely used in a variety of cancer chemotherapy, such as blood malignant tumor [1], a variety of adenocarcinoma [2][3][4][5], soft tissue sarcoma [6], and so on. However, long term and high dosages of DOX will lead to drug resistance [7], nausea [8], hair loss [9], and acute and chronic toxicity [10], which may lead to congestive heart failure [11].…”
Section: Introductionmentioning
confidence: 99%
“…These modifi cations lead to escape of SPIONs from RES. Comparing to our previous 64 Cu-labeled, antibody conjugated magnetic nanoparticles experiment [27], tumor uptake and tumor/liver, tumor/ kidney, tumor/blood ratios decreased from 12.5 ± 1.2%, 1.32 ± 0.10%, 1.83 ± 0.14%, 4.63 ± 0.64% to 5.29 ± 0.49%, 1.03 ± 0.08%, 1.15 ± 0.18%, 3.08 ± 0.67% at 24 h postinjection. Although tumor/organs ratios and tumor uptakes are smaller than antibody--conjugated SPIONs, folic acid-coated SPIONs are less expensive and can be prepared with relative ease.…”
Section: Discussionmentioning
confidence: 74%
“…[600] The emerging advances in nanotechnology have offered the possibility to develop mAb-based multifunctional nanoparticle delivery platforms for obtaining optimized pharmacokinetic profiles and expanded therapeutic capabilities compared with free anti-CD mAbs. [601,602]…”
Section: Cluster Of Differentiation Moleculesmentioning
confidence: 99%